INS and obesity disorder: Previous studies have demonstrated that angiotensin (1–7) intervention can decrease total fat volume, serum TGs, and epididymal adipocytes, while improving glucose tolerance, insulin sensitivity, and adipogenic differentiation in fatty liver, obesity, steatosis, and muscle tissue [19].